Angiotensin type 1a receptors in the subfornical organ are required for deoxycorticosterone acetate-salt hypertension

Hypertension

Volumn 61, Issue 3, 2013, Pages 716-722

  Hilzendeger, Aline M ^a   Cassell, Martin D ^a   Davis, Deborah R ^a   Stauss, Harald M ^b   Mark, Allyn L ^a   Grobe, Justin L ^a   Sigmund, Curt D ^a  

^a UNIVERSITY OF IOWA   (United States)

^b E11 SSH   (United States)

Author keywords

circumventricular organs; fluid balance; hypertension; mineralocorticoid; salt; site specific receptor deletion

Indexed keywords

ANGIOTENSIN 1A RECEPTOR; COPEPTIN; DEOXYCORTICOSTERONE ACETATE; GLUCOSE; SODIUM;

ANIMAL EXPERIMENT; ARCUATE NUCLEUS; AREA POSTREMA; ARTERIAL PRESSURE; BODY WEIGHT; CONFERENCE PAPER; CONTROLLED STUDY; FLUID BALANCE; GLUCOSE BLOOD LEVEL; HEART FUNCTION; HYPERNATREMIA; HYPERTENSION; HYPOKALEMIA; LATERAL BRAIN VENTRICLE; MALE; METABOLIC RATE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PHENOTYPE; POLYDIPSIA; POLYURIA; PREOPTIC NUCLEUS; PRIORITY JOURNAL; SODIUM EXCRETION; SODIUM INTAKE; SUBFORNICAL ORGAN; SUPRAOPTIC NUCLEUS; TRANSGENIC MOUSE; URINE VOLUME; VASOPRESSIN RELEASE;

ANIMALS; ARTERIAL PRESSURE; BIOLOGICAL MARKERS; DESOXYCORTICOSTERONE; GLYCOPEPTIDES; HEART; HYPERTENSION; MALE; MICE; MICE, TRANSGENIC; MINERALOCORTICOIDS; POLYDIPSIA; POLYURIA; RECEPTOR, ANGIOTENSIN, TYPE 1; RECOMBINATION, GENETIC; SODIUM; SUBFORNICAL ORGAN; SYMPATHETIC NERVOUS SYSTEM;

EID: 84874360680     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.111.00356     Document Type: Conference Paper

References (37)

1. Laragh JH. Biochemical profiling and the natural history of hypertensive diseases: low-renin essential hypertension, a benign condition. Circulation. 1971;44:971-974.
2. Selye H, Hall CE, Rowley EM. Malignant Hypertension Produced by Treatment with Desoxycorticosterone Acetate and Sodium Chloride. Can Med Assoc J. 1943;49:88-92.
3. Gavras H, Brunner HR, Laragh JH, Vaughan ED Jr, Koss M, Cote LJ, Gavras I. Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res. 1975;36:300-309.
4. Itaya Y, Suzuki H, Matsukawa S, Kondo K, Saruta T. Central reninangiotensin system and the pathogenesis of DOCA-salt hypertension in rats. Am J Physiol. 1986;251(2 pt 2):H261-H268.
5. Grobe JL, Grobe CL, Beltz TG, Westphal SG, Morgan DA, Xu D, de Lange WJ, Li H, Sakai K, Thedens DR, Cassis LA, Rahmouni K, Mark AL, Johnson AK, Sigmund CD. The brain Renin-angiotensin system controls divergent efferent mechanisms to regulate fluid and energy balance. Cell Metab. 2010;12:431-442.
6. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol. 2003;139:191-202.
7. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev. 1993;45:205-251.
8. Cottrell GT, Ferguson AV. Sensory circumventricular organs: central roles in integrated autonomic regulation. Regul Pept. 2004;117:11-23.
9. Johnson AK, Gross PM. Sensory circumventricular organs and brain homeostatic pathways. FASEB J. 1993;7:678-686.
10. Ferguson AV, Washburn DL, Latchford KJ. Hormonal and neurotransmitter roles for angiotensin in the regulation of central autonomic function. Exp Biol Med (Maywood). 2001;226:85-96.
11. Berecek KH, Barron KW, Webb RL, Brody MJ. Vasopressin-central nervous system interactions in the development of DOCA hypertension. Hypertension. 1982;4(3 pt 2):131-137.
12. Lind RW, Johnson AK. Subfornical organ-median preoptic connections and drinking and pressor responses to angiotensin II. J Neurosci. 1982;2:1043-1051.
13. Kubo T, Yamaguchi H, Tsujimura M, Hagiwara Y, Fukumori R. Blockade of angiotensin receptors in the anterior hypothalamic preoptic area lowers blood pressure in DOCA-salt hypertensive rats. Hypertens Res. 2000;23:109-118.
14. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol. 1988;255(3 pt 2):H646-H650.
15. Simpson JB, Routtenberg A. Subfornical organ: site of drinking elicitation by angiotensin II. Science. 1973;181:1172-1175.
16. Mangiapane ML, Simpson JB. Subfornical organ: forebrain site of pressor and dipsogenic action of angiotensin II. Am J Physiol. 1980;239:R382-R389.
17. Xue B, Beltz TG, Yu Y, Guo F, Gomez-Sanchez CE, Hay M, Johnson AK. Central interactions of aldosterone and angiotensin II in aldosterone-and angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2011;300:H555-H564.
18. Rateri DL, Moorleghen JJ, Balakrishnan A, Owens AP 3rd, Howatt DA, Subramanian V, Poduri A, Charnigo R, Cassis LA, Daugherty A. Endothelial cell-specific deficiency of Ang II type 1a receptors attenuates Ang II-induced ascending aortic aneurysms in LDL receptor-/-mice. Circ Res. 2011;108:574-581.
19. Sinnayah P, Lindley TE, Staber PD, Davidson BL, Cassell MD, Davisson RL. Targeted viral delivery of Cre recombinase induces conditional gene deletion in cardiovascular circuits of the mouse brain. Physiol Genomics. 2004;18:25-32.
20. Grobe JL, Buehrer BA, Hilzendeger AM, Liu X, Davis DR, Xu D, Sigmund CD. Angiotensinergic signaling in the brain mediates metabolic effects of deoxycorticosterone (DOCA)-salt in C57 mice. Hypertension. 2011;57:600-607.
21. Stauss HM, Moffitt JA, Chapleau MW, Abboud FM, Johnson AK. Baroreceptor reflex sensitivity estimated by the sequence technique is reliable in rats. Am J Physiol Heart Circ Physiol. 2006;291: H482-H483.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001;25:402-408.
23. Fink GD, Johnson RJ, Galligan JJ. Mechanisms of increased venous smooth muscle tone in desoxycorticosterone acetate-salt hypertension. Hypertension. 2000;35(1 pt 2):464-469.
24. Crofton JT, Share L, Shade RE, Lee-Kwon WJ, Manning M, Sawyer WH. The importance of vasopressin in the development and maintenance of DOC-salt hypertension in the rat. Hypertension. 1979;1:31-38.
25. Nickel CH, Bingisser R, Morgenthaler NG. The role of copeptin as a diagnostic and prognostic biomarker for risk stratification in the emergency department. BMC Med. 2012;10:7.
26. Fluharty SJ, Epstein AN. Sodium appetite elicited by intracerebroventricular infusion of angiotensin II in the rat: II. Synergistic interaction with systemic mineralocorticoids. Behav Neurosci. 1983;97:746-758.
27. Sakai K, Agassandian K, Morimoto S, Sinnayah P, Cassell MD, Davisson RL, Sigmund CD. Local production of angiotensin II in the subfornical organ causes elevated drinking. J Clin Invest. 2007;117: 1088-1095.
28. Phillips MI, Wielbo D, Gyurko R. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 1994;46:1554-1556.
29. Zimmerman MC, Lazartigues E, Lang JA, Sinnayah P, Ahmad IM, Spitz DR, Davisson RL. Superoxide mediates the actions of angiotensin II in the central nervous system. Circ Res. 2002;91:1038-1045.
30. Yemane H, Busauskas M, Burris SK, Knuepfer MM. Neurohumoral mechanisms in deoxycorticosterone acetate (DOCA)-salt hypertension in rats. Exp Physiol. 2010;95:51-55.
31. Mangiapane ML, Simpson JB. Subfornical organ lesions reduce the pressor effect of systemic angiotensin II. Neuroendocrinology. 1980;31:380-384.
32. Hendel MD, Collister JP. Contribution of the subfornical organ to angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol. 2005;288:H680-H685.
33. Osborn JW, Jacob F, Hendel M, Collister JP, Clark L, Guzman PA. Effect of subfornical organ lesion on the development of mineralocorticoid-salt hypertension. Brain Res. 2006;1109:74-82.
34. Grobe J, Rowland N, Katovich M. Role of angiotensin II and the subfornical organ in the pharmacological actions of ethanol. Alcohol Alcohol. 2004;39:410-417.
35. Bai D, Renaud LP. ANG II AT1 receptors induce depolarization and inward current in rat median preoptic neurons in vitro. Am J Physiol. 1998;275(2 pt 2):R632-R639.
36. Dewald M, Braun HA, Huber MT, Zwingmann D, Roth J, Voigt K. Interactions of temperature and angiotensin II in paraventricular neurons of rats in vitro. Pflugers Arch. 2002;444:117-125.
37. Arakawa H, Chitravanshi VC, Sapru HN. The hypothalamic arcuate nucleus: a new site of cardiovascular action of angiotensin-(1-12) and angiotensin II. Am J Physiol Heart Circ Physiol. 2011;300:H951-H960.